1117

Welcome to the November issue of The Ophthalmologist! Upfront’s topics include a new 24-hour IOP monitor and incidences of PCO with different IOL materials. In My View sees Juan Carlos-Serna discuss what ophthalmologists can do when disaster strikes, Roy Rubinfeld says it is time to drop the epi-on crosslinking debate, and João Barbosa-Breda focuses on how metabolomics will shape the future of glaucoma care. In our Feature, Javier Zarranz-Ventura, David Johnston and Adnan Tufail pay homage to Robert Johnston – one of ophthalmology’s true figure heads who shaped the practice as we know it today. NextGen sees Peter Kaiser overview drug delivery devices for neovascular disease, and in Profession, Robert Osher talks about setting up a successful cataract meeting and C. Andrès Benatti tackles the dogma of ‘brain drain’. Finally, we Sit Down With Cynthia Matossian, Founder and Medical Director of Matossian Eye Associates.

Register to download

Articles featured in this issue

Business & Profession Other

Our Rob

11/02/2017 | Mark Hillen

Rob Johnston made a real difference in his lifetime – and his story is well worth telling.

Subspecialties Glaucoma

Feeling the Pressure

11/02/2017 | Ruth Steer

Is a low-cost pressure-sensing contact lens the key to 24-hour IOP measurements?

Subspecialties Cataract

Polymers and PCO: the IOL Material Lowdown

11/02/2017 | Mark Hillen

When you have a big dataset, what was once suspected can now be confirmed.

Subspecialties Retina

Does Size Really Matter?

11/02/2017 | Mark Hillen

A (much) closer look at vitrectomy instrument size.

Subspecialties Cataract

Evidence for CME Prevention

11/02/2017 | Ruth Steer

PREMED study results – do cataract surgeons now have an answer on how best to prevent CME?

Business & Profession Other

Retinal T-Regimen

11/02/2017 | Ruth Steer

Could retinopathies one day be treated by boosting immunosuppressive Treg cells in the retina?

Subspecialties Other

Electric Tears?

11/02/2017 | Ruth Steer

The piezoelectric effect of teardrop protein.

Subspecialties Basic & Translational Research

Image of the Month

11/02/2017

An excerpt from the "Science of Sight" exhibition.

Business & Profession Other

When Disaster Strikes

11/02/2017 | Juan Carlos Serna-Ojeda

What can an ophthalmologist do in times of adversity? A great deal.

Subspecialties Cornea / Ocular Surface

Time to Drop the Debate

11/02/2017 | Roy Rubinfeld

It shouldn't be about epi-on or epi-off CXL… The focus should be on what's best for patients.

Subspecialties Glaucoma

Move Out of the Tunnel… and into the Light!

11/02/2017 | João Barbosa-Breda

When it comes to glaucoma care, metabolomics could well be the future.

Business & Profession Other

Rob, Remembered

11/02/2017 | Javier Zarranz-Ventura, David Johnston & Adnan Tufail

Robert L. Johnston made a real difference in his lifetime. His legacy? Reshaping ophthalmology as we know it.

Business & Profession Other

Going about things in the right way

11/03/2017 | Javier Zarranz-Ventura, David Johnston & Adnan Tufail

I got involved with Medisoft through the retina side – seeing the fantastic EMR analysis work they were doing on cataract surgery...

Subspecialties Retina

Keep On Keeping On

11/02/2017 | Peter Kaiser

The future of retinal drug delivery for the treatment of neovascular disease.

Subspecialties Professional Development

Straight Talking

11/02/2017 | Robert Osher

Why Robert Osher decided to start his own meeting, what’s on offer, and how he runs it.

Business & Profession Other

Brain Circulation

11/02/2017 | C. Andrés Benatti

It’s not a brain drain when young, gifted surgeons and researchers work abroad.

Subspecialties Professional Development

Fortune Favors the True

11/02/2017 | Cynthia Matossian

Cynthia Matossian, Founder and Medical Director of Matossian Eye Associates

Subspecialties Retina

Retinal Imaging: The Big Picture

11/07/2017 | Sponsored by Optos

Highlights from the Optos satellite meeting held at the 17th EURETINA Congress, Barcelona.

Other issues of 2017

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: